Catastrophic Disruptions in Clinical Trials.

Abstract

HomeCirculationVol. 146, No. 5Catastrophic Disruptions in Clinical Trials No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextCatastrophic Disruptions in Clinical Trials Josephine Harrington, MD, G. Michael Felker, MD, MHS and Robert J. Mentz, MD Josephine HarringtonJosephine Harrington https://orcid.org/0000-0001-5169-117X Department of Medicine, Division of Cardiology, Duke University, Durham, NC. Duke Clinical Research Institute, Durham, NC. Search for more papers by this author , G. Michael FelkerG. Michael Felker https://orcid.org/0000-0002-5931-1239 Department of Medicine, Division of Cardiology, Duke University, Durham, NC. Duke Clinical Research Institute, Durham, NC. Search for more papers by this author and Robert J. MentzRobert J. Mentz Correspondence to: Robert J. Mentz, MD, Duke University School of Medicine, 200 Trent Dr, 4th Floor, Orange Zone, Room 4221, Durham, NC 27710. Email E-mail Address: [email protected] https://orcid.org/0000-0002-3222-1719 Department of Medicine, Division of Cardiology, Duke University, Durham, NC. Duke Clinical Research Institute, Durham, NC. Search for more papers by this author Originally published1 Aug 2022https://doi.org/10.1161/CIRCULATIONAHA.122.060541Circulation. 2022;146:369–371FootnotesCirculation is available at www.ahajournals.org/journal/circThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 370.Correspondence to: Robert J. Mentz, MD, Duke University School of Medicine, 200 Trent Dr, 4th Floor, Orange Zone, Room 4221, Durham, NC 27710. Email robert.[email protected]edu